Clinical experience with the use of the intestinal antibiotic Rifaximin for celiac disease

Author:

Оrеshkо L. S.1ORCID,Semenova E. A.1ORCID

Affiliation:

1. North-Western State Medical University named after I.I. Mechnikov

Abstract

The article is devoted to new possibilities in the treatment of hereditary intestinal diseases, accompanied by a decrease in kinetic activity or the absence of enteric enzymes, including celiac disease. Despite strict adherence to the elimination diet, some patients develop IBS-like symptoms, which may be caused by a violation of the qualitative and quantitative composition of the intestinal microflora. Dysbiotic disorders play a role in the pathogenesis of the appearance of IBS-like symptoms and complicate the course of celiac disease, which requires the use of antibacterial drugs. The presence of side effects when using systemic antibacterial drugs limits their use. In this regard, the search for ways to correct the intestinal microflora, as well as the study of various approaches to maintaining the intestinal microecology in a state of physiological equilibrium in patients with celiac disease, are relevant for medical science. The article presents a clinical example of the successful and safe use of a drug with low absorption, high antibacterial activity – rifaximin in a patient with celiac disease to correct dysbiotic disorders.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference24 articles.

1. Sahoo S., Thiele I. Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells. Hum Mol Genet. 2013;22(13):2705–2722. doi:10.1093/hmg/ddt119.

2. Parfenov A.I., Bykova S.V., Sabelnikova E.A., Mayev I.V., Baranov A.A., Bakulin I.G., Krums L.M., Belmer S.V., Borovik T.E., Zakharova I.N., Dmitrieva Yu.A., Roslavtseva E.A., Kornienko E.A., Khavkin A.I., Potapov A.S., Revnova M.O., Mukhina Yu.G., Shcherbakov P.L., Fedorov E.D., Belousova E.A., Khalif I.L., Khomeriki S.G., Rotin D.L., Vorobyova N.G., Pivnik A.V., Gudkova R.B., Chernin V.V., Vokhmyanina N.V., Pukhlikova T.V., Degtyarev D.A., Damulin I.V., Mkrtumyan A.M., Dzhulay G.S., Tetruashvili N.K., Baranovsky A.Yu., Nazarenko L.I., Kharitonov A.G., Loranskaya I.D., Sayfutdinov R.G., Livzan M.A., Abramov D.A., Osipenko M.F., Oreshko L.S., Tkachenko E.I., Sitkin S.I., Efremov L.I. AllRussian consensus on the diagnosis and treatment of celiac disease in children and adults. Terapevticheskiy arkhiv = Therapeutic archive. 2017;89(3):94-107. (In Russ.) doi: 10.17116/terarkh201789394-107.

3. Sitkin S.I., Vakhitov T.Y., Tkachenko E.I., Oreshko L.S., Zhigalova T.N., Radchenko V.G., Seliverstov P.V., Avalueva E.B., Suvorova M.A., Komlichenko E.V. Intestinal microbiota in ulcerative colitis and celiac disease. Ehksperimental’naya i klinicheskaya gastroehnterologiya = Experimental and clinical gastroenterology. 2017;(1):8-30. (In Russ.) Available at: http://www.nogr.org/index.php/2017r/01-137.

4. Lazebnik L.B., Nemtsov V.I., Oreshko L.S., Tkachenko E.I., Osipenko M.F., Radchenko P.G., Seliverstov P.V., Solovyova E.A., Shabanova A.A., Zhuravleva M.S., Karpov A.A., Fedorov E.D. Recommendations for the diagnosis and treatment of adult celiac disease Ehksperimental’naya i klinicheskaya gastroehnterologiya = Experimental and Clinical Gastroenterology Journal. 2015;(5):4-13. (In Russ.) Available at: https://cyberleninka.ru/article/n/rekomendatsii-po-diagnostike-ilecheniyutseliakii-vzroslyh.

5. Husby S., Koletzko S Korponay-Szabo I.R., Mearin M.L., Phillips A., Shamir R., Troncone R., Giersiepen K., Branski D., Catassi C., Lelgeman M., Maki M., Ribes-Koninckx C., Ventura A., Zimmer K.P. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-60. doi: 10.1097/MPG.0b013e31821a23d0.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3